Beijing joins WHO-backed COVAX program to support initiative against ‘vaccine nationalism’

Close to the finish line.. Corona vaccines “injection or nasal

She added later at a daily news briefing that many Chinese vaccine companies expressed a willingness to join the partnership and that China would buy vaccines for about 1% of its population through COVAX.

The vaccine under development by AstraZeneca and the University of Oxford is also being reviewed under this new, speedier framework by the EMA.

Foreign ministry spokesperson Hua Chunying said Friday that Beijing had formally signed up to the Covid-19 Vaccines Global Access (Covax) Facility, an worldwide initiative co-led by the World Health Organization (WHO), which aims to provide equitable access to safe and effective coronavirus vaccines.

Vaccine availability is likely to be limited initially, hence it will be important to clearly identify goals of national vaccination strategy, she said. He explained the now working on producing all six potential vaccines across more than 23 manufacturing facilities.

China is the biggest economy to support COVAX after the USA and Russian Federation turned their backs on the program. Available vaccines should first be provided to priority populations and then expanded to others.

The country signed an agreement with Gavi, the co-leader of the project, on Thursday, China's foreign ministry said.

One of BioNTech's messenger-RNA vaccine candidates is now in stage-three trials.

Close to the finish line.. Corona vaccines “injection or nasal

At least 42 possible vaccines are being considered for the trial but the World Health Organization representative said only eight or nine are close to meeting the requirements, with two or three vaccines being considered as "frontrunners".

He said the move is necessary as the Ministry is at capacity with the storage of flu vaccines which are due to be given out this year.

World Health Organization says the goal of COVAX is by the end of 2021 to deliver two billion doses of safe, effective vaccines that have passed regulatory approval and/or World Health Organization prequalification.

Over 150 countries so far have participated in the alliance, which pledges that all countries within the group, regardless of income levels, will have equal access to these vaccines once they are developed.

It is created to discourage national governments from hoarding COVID-19 vaccines and to focus on first vaccinating the most high-risk people in every country.

Ensuring continued WHO support, the Regional Director said, "Together we must continue to strengthen the Covid-19 response by aggressively applying the basic public health measures, and also looking ahead and ensuring that we make full use of emerging tools to control spread, save lives and minimize impact".